Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARYA

ARYA Sciences Acquisition Corp III (ARYA) Stock Price, News & Analysis

About ARYA Sciences Acquisition Corp III Stock (NASDAQ:ARYA)

Advanced Chart

Key Stats

Today's Range
$10.77
$11.25
50-Day Range
$9.91
$11.16
52-Week Range
$9.82
$25.89
Volume
366,228 shs
Average Volume
320,123 shs
Market Capitalization
$186.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ARYA Sciences Acquisition Corp III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

Receive ARYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARYA Sciences Acquisition Corp III and its competitors with MarketBeat's FREE daily newsletter.

ARYA Stock News Headlines

Oaktree Acquisition Corp. III Life Sciences (OACCU)
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Mphasis appoints Ajay Arya to head M&A
Nautilus Biotechnology Inc (NAUT)
See More Headlines

ARYA Stock Analysis - Frequently Asked Questions

ARYA Sciences Acquisition Corp III (ARYA) raised $125 million in an initial public offering (IPO) on Friday, August 7th 2020. The company issued 12,500,000 shares at $10.00 per share. Jefferies and Goldman Sachs acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARYA Sciences Acquisition Corp III investors own include Ampio Pharmaceuticals (AMPE), bluebird bio (BLUE), Forte Biosciences (FBRX), Navidea Biopharmaceuticals (NAVB), Outlook Therapeutics (OTLK), Electrameccanica Vehicles (SOLO) and Sequential Brands Group (SQBG).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
NASDAQ:ARYA
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.30 per share
Price / Book
37.20

Miscellaneous

Free Float
N/A
Market Cap
$186.48 million
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:ARYA) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners